ARTICLE | Clinical News
ET-743 anti-cancer compound: PharmaMar began Phase I trials
June 10, 1996 7:00 AM UTC
PharmaMar, Madrid, Spain Product: ET-743 anti-cancer compound derived from a marine organism Indication: Cancer Status: PharmaMar began Phase I trials in France, and presently will begin additional ...